Sold as Wegovy, the self-administered injectable is given at a higher once-a-week dosage of 2.4 mg. It is intended as a weight-loss medication for adults with an "overweight" body mass index (BMI) between 27 and 29 who also struggle with at least one weight-related health issue...
Medication utilization changes included 38% of the hypertension agents were eliminated or reduced and 29% of the oral diabetes agents were discontinued. Conclusion This study provides evidence that medically supervised weight loss promotes medical clearance for non-bariatric surgery in obese Veterans who ...
"I've been trying to lose weight for so long," Strecker-Gaudreau said. She mentioned that she was on the highest dose of Wegovy available in 2022 but did not see any results. After her insurance stopped covering the medication, she said her doctor ...
Indirect costs included healthcare, medication, medical devices, and transportation (Additional file 7). It was assumed that patients with mild hyperkalemia (not leading to hospitalisation) were treated with either calcium polystyrene sulfonate for 40 days, sodium polystyrene sulfonate for 40 days, ...
not when it comes to antiobesity medication prices. Obesity (Silver Spring). 2023;31(5):1183-1184. doi:10.1002/oby.23751PubMedGoogle ScholarCrossref State Medicaid Coverage and Reimbursement of Antiobesity Medications JAMA Research Letter April 9, 2024 This study examines state Medicaid ...
85.7% and 33.3% of patients achieved ≥ 5% and 10% weight loss target respectively at 52 weeks. 92.3% and 72.2% achieved remission of pre-diabetes by 6 and 12 months respectively. Liraglutide 3.0 mg was well-tolerated with only 10% discontinuing medication due to tolerability issues. ...
Resource Utilization and Costs of Care for Treatment of Chronic Headache. In: AHRQ Technical Reviews and Summaries. US Agency for Health Care Policy and Research; 1999. 3. Lipton RB, Hutchinson S, Ailani J, et al. Discontinuation of acute prescription medication for migraine: results...
摘要: Objectives Unintentional weight loss is a prevalent and costly clinical problem among nursing home (NH) residents. One of the most common nutrition interventions for residents at risk for weight loss...关键词: Nursing homes weight loss intervention nutrition supplementation ...
GLP-1 medication use for type 2 diabetes has soared.JAMA 332, 952–953 (2024). PubMed Google Scholar Sodhi, M., Rezaeianzadeh, R., Kezouh, A. & Etminan, M. Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss. JAMA 330, ...
Background This trial aimed to evaluate the effectiveness of motivational interviewing (MINT) among medication non-adherent hypertensive patients attending... KJ Khadoura,E Shakibazadeh,MA Mansournia,... - 《European Journal of Cardiovascular Nursing》 被引量: 0发表: 2021年 Motivational interviewing ...